This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 2015; 21: 389–401.e1.
Grauer O, Wolff D, Bertz H, Greinix H, Kühl JS, Lawitschka A et al. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Brain 2010; 133: 2852–2865.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host-disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
Freynhagen R, Baron R, Gockel U, Tölle TR . painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911–1920.
Smith EM, Beck SL, Cohen J . The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum 2008; 35: 96–102.
Kraus PD, Wolff D, Grauer O, Angstwurm K, Jarius S, Wandinger KP et al. Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host-disease. PLoS ONE 2012; 7: e44922.
Koeppen S, Thirugnanasambanthan A, Koldehoff M . Neuromuscular complications after hematopoietic cell transplantation. Support Care Cancer 2014; 22: 2337–2341.
Sing G, Valdez BC, Li Y, Liu Y, Champlin RE, Andersson BS . Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FMS-like tyrosine kinase 3 internal tandem duplications-positive acute myeloid leukemia cells. Biol Blood Marrow Transplant 2014; 20: 1687–1695.
Horga A, Pitceathly RD, Blake JC, Woodward CE, Zapater P, Fratter C et al. Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia. Brain 2014; 137: 3200–3212.
Low PA, Singer W . Treatment-induced neuropathy of diabetes: an energy crisis? Brain 2015; 138: 2–3.
Gibbons CH, Freeman R . Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain 2015; 138: 43–52.
Argyriou AA, Iconomou G, Kalofonos HP . Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood 2008; 112: 1593–1599.
Openshaw H Neurologic maniphestations of chronic graft versus host disease. In: Vogelsang GB, Pavletic SZ (eds). Chronic Graft Versus Host Disease. Cambridge University Press: New York, NY, USA, 2009, pp 243–251.
Poncelet AN, Connolly NK . Peripheral neuropathy in scleroderma. Muscle Nerve 2003; 28: 330–335.
Paik JJ, Mammen AL, Wigley FM, Shah AA, Hummers LK, Polydefkis M . Symptomatic and electrodiagnostic features of peripheral neuropathy in scleroderma. Arthritis Care Res (Hoboken), (e-pub ahead of print 14 December 2015; doi: 10.1002/acr.22818).
Statistical analyses were performed by Assist Professor Milan Milosevic MD PhD, University of Zagreb School of Medicine. We show our gratitude to Dina Ljubas, Ljubica Rajic, Nadira Durakovic, Zinaida Peric, Davorka Dusek, Ines Bojanic, Magdalena Grce, Drago Batinic, Renata Zadro, Igor Petricek, Tamara Vukic, Ema Prenc and Iva Ozana Prah for their valuable work and collaboration in this multidisciplinary team. The opinions expressed here are those of the authors and do not represent the official position of the NIH or the US Government. All patients or their parents (for paediatric patients) signed informed consent approved by ethical committees of the University Hospital Centre and Medical School University of Zagreb, Zagreb, Croatia. This work is funded by the Unity Through Knowledge Fund project entitled ‘Clinical and biological factors determining severity and activity of chronic GvHD after allogeneic hematopoietic stem cell transplantation’. In part support is also provided by the Center for Cancer Reserach, the intramural program of the National Cancer Institute, National Institutes of Health, USA.
Ervina B, SZP, RV, LD and DN contributed to the conception and design of the work. Ervina B, VD, LD, DP, MMS, RC, TKP, Ernest B, MB, RSS, IA, OM and RV contributed to acquisition and analysis of the data. Ervina B, VD, LD, DP, Ernest B, MB, LMC, MMS, RC, TKP, IA, RV, DN and SZP contributed to interpretation of the data. The manuscript was drafted by Ervina B, VD, Ernest B, DP and LMC. All authors revised the work critically for important intellectual content, approved final version of the manuscript and agreed to be accountable for all aspects of the work.
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bilic, E., Delimar, V., Desnica, L. et al. High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD. Bone Marrow Transplant 51, 1513–1517 (2016). https://doi.org/10.1038/bmt.2016.158
This article is cited by
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series
Bone Marrow Transplantation (2022)
Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
Bone Marrow Transplantation (2021)
Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation
Bone Marrow Transplantation (2018)